Gossamer Bio, Inc. releases Q3 financial results, showcasing its performance in the pharmaceutical preparations sector amid competitive challenges.
| Name | Gossamer Bio, Inc. |
|---|---|
| CIK | 0001728117 |
| Tickers | GOSS |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 475461709 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858) 684-1300 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Gossamer Bio, Inc. releases Q3 financial results, showcasing its performance in the pharmaceutical preparations sector amid competitive challenges.
Gossamer Bio announces third quarter financial results and the submission of a New Drug Application for seralutinib, marking a significant milestone for the company.
FMR LLC has acquired a 10.9% stake in Gossamer Bio, Inc., signaling strong interest in the pharmaceutical preparations sector.
Gossamer Bio, Inc. reveals significant changes in its shareholder structure, with D. E. Shaw & Co., L.P. reducing its stake below 5%.
490 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | S-3 | S-3 | 0001728117-26-000123 | 333-300084 | 261561639 | 33 | 520979 | 1 | 1 | |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128345 | 005-91334 | 261561335 | 34 | 17145 | |||
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001728117-26-000116 | 001-38796 | 261541252 | 34 | 249679 | 1 | 1 |
| 2026-11-10 | 10-Q | 10-Q | 0001728117-26-000114 | 001-38796 | 261541237 | 34 | 8464919 | 1 | 1 | |
| 2026-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-050449 | 005-91334 | 261531854 | 34 | 23809 | |||
| 2026-11-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002941 | 005-91334 | 261529765 | 34 | 11471 | |||
| 2026-10-29 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-120319 | 005-91334 | 261503612 | 34 | 67443 | |||
| 2026-10-28 | 8-K | 8-K | 5.07 | 0001728117-26-000109 | 001-38796 | 261495673 | 34 | 145304 | 1 | 1 |
| 2026-10-08 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-114792 | 005-91334 | 261450973 | 34 | 54837 | |||
| 2026-09-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-111463 | 005-91334 | 261418734 | 34 | 87977 | |||
| 2026-09-28 | 8-K | 8-K | 8.01 | 0001728117-26-000106 | 001-38796 | 261417180 | 34 | 138624 | 1 | 1 |
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063624 | 5510 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063619 | 5530 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063616 | 5465 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063610 | 5518 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063606 | 5481 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063601 | 5528 | ||||||
| 2026-09-25 | 4 | FORM 4 | 0001628280-26-063593 | 5526 | ||||||
| 2026-09-23 | 8-K | 8-K | 8.01 | 0001728117-26-000104 | 001-38796 | 261401088 | 34 | 145460 | 1 | 1 |
| 2026-09-22 | 3 | FORM 3 | 0001628280-26-063097 | 506430 | ||||||
| 2026-09-16 | DEF 14A | DEF 14A | 0001728117-26-000102 | 001-38796 | 261384140 | 34 | 4851558 | 1 | 1 | |
| 2026-09-16 | 8-K | 8-K | 5.02,9.01 | 0001728117-26-000101 | 001-38796 | 261383788 | 34 | 165102 | 1 | 1 |
| 2026-09-11 | 8-K | 8-K | 3.03,5.03,8.01,9.01 | 0001728117-26-000094 | 001-38796 | 261372718 | 34 | 194782 | 1 | 1 |
| 2026-09-09 | 8-K | 8-K | 8.01,9.01 | 0001728117-26-000091 | 001-38796 | 261366878 | 34 | 174118 | 1 | 1 |
| 2026-09-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001728117-26-000088 | 021-596541 | 261362657 | 33 | 15677 | ||
| 2026-09-03 | PRE 14A | PRE 14A | 0001728117-26-000086 | 001-38796 | 261358288 | 34 | 4762621 | 1 | 1 | |
| 2026-09-03 | 8-K | 8-K | 5.03,9.01 | 0001728117-26-000085 | 001-38796 | 261358247 | 34 | 443262 | 1 | 1 |
| 2026-08-26 | 4 | FORM 4 | 0001553179-26-000005 | 6135 | ||||||
| 2026-08-26 | 4 | FORM 4 | 0001857256-26-000006 | 6095 | ||||||
| 2026-08-26 | 4 | FORM 4 | 0002003059-26-000008 | 6150 | ||||||
| 2026-08-26 | 4 | FORM 4 | 0001740847-26-000006 | 9345 | ||||||
| 2026-08-26 | 4 | FORM 4 | 0001352620-26-000006 | 9394 | ||||||
| 2026-08-26 | 8-K | 8-K | 5.03,9.01 | 0001728117-26-000079 | 001-38796 | 261322556 | 34 | 265788 | 1 | 1 |
| 2026-08-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-100440 | 005-91334 | 261312120 | 34 | 92654 | |||
| 2026-08-21 | 8-K | 8-K | 1.01,3.02,5.03,7.01,9.01 | 0001728117-26-000077 | 001-38796 | 261301750 | 34 | 1546877 | 1 | 1 |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001728117-26-000073 | 001-38796 | 261273048 | 34 | 254281 | 1 | 1 |
| 2026-08-13 | 10-Q | 10-Q | 0001728117-26-000072 | 001-38796 | 261273032 | 34 | 8069019 | 1 | 1 | |
| 2026-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-035186 | 005-91334 | 261217357 | 34 | 22953 | |||
| 2026-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002802 | 005-91334 | 261216900 | 34 | 10760 | |||
| 2026-07-27 | 8-K | 8-K | 1.01,1.02,2.02,7.01,8.01,9.01 | 0001728117-26-000064 | 001-38796 | 261205658 | 34 | 442041 | 1 | 1 |
| 2026-07-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-086735 | 005-91334 | 261202681 | 34 | 70826 | |||
| 2026-07-15 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0001728117-26-000061 | 001-38796 | 261175655 | 34 | 7655114 | 1 | 1 |
| 2026-07-01 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-080004 | 005-91334 | 261147518 | 34 | 64789 | |||
| 2026-07-01 | 8-K | 8-K | 7.01,9.01 | 0001728117-26-000057 | 001-38796 | 261142890 | 34 | 156207 | 1 | 1 |
| 2026-06-17 | 8-K | 8-K | 7.01,9.01 | 0001728117-26-000054 | 001-38796 | 261096634 | 34 | 173271 | 1 | 1 |
| 2026-06-11 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-073089 | 005-91334 | 261084764 | 34 | 72752 | |||
| 2026-06-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-073064 | 005-91334 | 261084653 | 34 | 25827 | |||
| 2026-06-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001404574-26-000021 | 005-91334 | 261083898 | 34 | 12645 | |||
| 2026-06-09 | DEF 14A | DEF 14A | 0001728117-26-000052 | 001-38796 | 261076337 | 34 | 4292543 | 1 | 1 | |
| 2026-06-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001301396-26-000003 | 005-91334 | 261074705 | 34 | 620028 | |||
| 2026-06-05 | 4 | FORM 4 | 0001728117-26-000047 | 5726 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0002015102-26-000001 | 5763 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0001538894-26-000002 | 5775 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0001512984-26-000001 | 5773 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0001859810-26-000003 | 5755 | ||||||
| 2026-06-05 | 4 | FORM 4 | 0002015114-26-000001 | 5771 | ||||||
| 2026-06-05 | 8-K | 8-K | 1.01,1.02,2.03,3.02,7.01,9.01 | 0001728117-26-000045 | 001-38796 | 261066535 | 34 | 128990604 | 1 | 1 |
| 2026-06-05 | 8-K | 8-K | 5.07 | 0001728117-26-000042 | 001-38796 | 261066141 | 34 | 156439 | 1 | 1 |
| 2026-06-02 | 8-K | 8-K | 8.01,9.01 | 0001728117-26-000040 | 001-38796 | 261053656 | 34 | 174001 | 1 | 1 |
| 2026-05-18 | PRE 14A | PRE 14A | 0001728117-26-000038 | 001-38796 | 26990765 | 34 | 4275485 | 1 | 1 | |
| 2026-05-18 | DEFA14A | DEFA14A | 0001728117-26-000037 | 001-38796 | 26990764 | 34 | 552851 | |||
| 2026-05-18 | 8-K | 8-K | 1.01,2.02,5.02,7.01,8.01 | 0001728117-26-000036 | 001-38796 | 26990763 | 34 | 774752 | 1 | 1 |
| 2026-05-15 | 10-Q | 10-Q | 0001728117-26-000032 | 001-38796 | 26986705 | 34 | 6111009 | 1 | 1 | |
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-006204 | 005-91334 | 26978573 | 34 | 11744 | |||
| 2026-04-24 | ARS | ARS | 0001728117-26-000029 | 001-38796 | 26893499 | 34 | 29177621 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001728117-26-000028 | 001-38796 | 26893468 | 34 | 283034 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001728117-26-000027 | 001-38796 | 26893450 | 34 | 3554986 | 1 | 1 | |
| 2026-04-09 | 8-K | 8-K | 3.01 | 0001728117-26-000022 | 001-38796 | 26851519 | 34 | 144992 | 1 | 1 |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001439 | 005-91334 | 26801487 | 34 | 7163 | |||
| 2026-03-24 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001085146-26-000283 | 005-91334 | 26787077 | 34 | 10744 | |||
| 2026-03-20 | 4 | FORM 4 | 0001867872-26-000004 | 53380 | ||||||
| 2026-03-20 | 4 | FORM 4 | 0001857256-26-000004 | 53382 | ||||||
| 2026-03-20 | 4 | FORM 4 | 0002003059-26-000006 | 12438 | ||||||
| 2026-03-20 | 4 | FORM 4 | 0001352620-26-000004 | 45250 | ||||||
| 2026-03-20 | 4 | FORM 4 | 0001740847-26-000004 | 49326 | ||||||
| 2026-03-20 | 4 | FORM 4 | 0001553179-26-000004 | 45233 | ||||||
| 2026-03-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000860 | 333-293009 | 26772218 | 33 | 1760 | ||
| 2026-03-17 | POS AM | POS AM | 0001728117-26-000020 | 333-293009 | 26761932 | 33 | 299913 | |||
| 2026-03-17 | 8-K | 8-K | 2.02,9.01 | 0001728117-26-000018 | 001-38796 | 26761714 | 34 | 244502 | 1 | 1 |
| 2026-03-17 | 10-K | 10-K | 0001728117-26-000017 | 001-38796 | 26761678 | 34 | 10020082 | 1 | 1 | |
| 2026-03-17 | POSASR | POSASR | 0001728117-26-000016 | 333-293009 | 26761650 | 33 | 584548 | 1 | 1 | |
| 2026-03-02 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001404574-26-000006 | 005-91334 | 26705393 | 34 | 11000 | |||
| 2026-02-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001072613-26-000213 | 005-91334 | 26673661 | 34 | 89598 | |||
| 2026-02-23 | 8-K | 8-K | 8.01 | 0001728117-26-000004 | 001-38796 | 26662178 | 34 | 3489951 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-26-002007 | 005-91334 | 26640727 | 34 | 11598 | |||
| 2026-01-28 | S-3ASR | S-3ASR | 0001728117-26-000002 | 333-293009 | 26572412 | 33 | 990910 | 1 | 1 | |
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000670 | 005-91334 | 26545827 | 34 | 10830 | |||
| 2026-01-05 | 4 | FORM 4 | 0001352620-26-000002 | 7868 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001740847-26-000002 | 7818 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0002003059-26-000003 | 7883 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001867872-26-000002 | 7823 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001857256-26-000002 | 7134 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001553179-26-000002 | 8561 | ||||||
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001728117-25-000082 | 001-38796 | 251455218 | 34 | 244584 | 1 | 1 |
| 2025-11-05 | 10-Q | 10-Q | 0001728117-25-000081 | 001-38796 | 251455212 | 34 | 6881036 | 1 | 1 | |
| 2025-10-02 | 4 | FORM 4 | 0002003059-25-000004 | 5624 | ||||||
| 2025-10-02 | 4 | FORM 4 | 0001553179-25-000004 | 6302 | ||||||
| 2025-10-02 | 4 | FORM 4 | 0001740847-25-000003 | 5558 | ||||||
| 2025-10-02 | 4 | FORM 4 | 0001867872-25-000003 | 5564 | ||||||
| 2025-10-02 | 4 | FORM 4 | 0001352620-25-000004 | 5605 | ||||||
| 2025-10-02 | 4 | FORM 4 | 0001857256-25-000004 | 4875 | ||||||
| 2025-09-25 | 8-K | 8-K | 3.02 | 0001728117-25-000076 | 001-38796 | 251340364 | 34 | 147302 | 1 | 1 |
| 2025-08-20 | 4 | FORM 4 | 0001728117-25-000072 | 4432 | ||||||
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0001728117-25-000069 | 001-38796 | 251184774 | 34 | 249453 | 1 | 1 |
| 2025-08-05 | 10-Q | 10-Q | 0001728117-25-000068 | 001-38796 | 251184759 | 34 | 6749675 | 1 | 1 | |
| 2025-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000900 | 005-91334 | 251159998 | 34 | 6170 | |||
| 2025-07-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003058 | 005-91334 | 251132227 | 34 | 10692 | |||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000061 | 5623 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000059 | 5631 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000057 | 5650 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000055 | 5586 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000053 | 5598 | ||||||
| 2025-06-26 | 4 | FORM 4 | 0001728117-25-000051 | 5623 | ||||||
| 2025-06-25 | 8-K | 8-K | 5.02,5.07 | 0001728117-25-000043 | 001-38796 | 251073587 | 34 | 165029 | 1 | 1 |
| 2025-06-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001728117-25-000040 | 001-38796 | 251048535 | 34 | 184817 | 1 | 1 |
| 2025-05-15 | 8-K | 8-K | 2.02,9.01 | 0001728117-25-000037 | 001-38796 | 25952450 | 34 | 242392 | 1 | 1 |
| 2025-05-15 | 10-Q | 10-Q | 0001728117-25-000036 | 001-38796 | 25952393 | 34 | 5757569 | 1 | 1 | |
| 2025-04-29 | ARS | ARS | 0001728117-25-000031 | 001-38796 | 25887007 | 34 | 17700794 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0001728117-25-000030 | 001-38796 | 25886989 | 34 | 272705 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0001728117-25-000029 | 001-38796 | 25886974 | 34 | 3851486 | 1 | 1 | |
| 2025-03-13 | S-8 | S-8 | 0001728117-25-000023 | 333-285779 | 25735659 | 33 | 191534 | |||
| 2025-03-13 | 8-K | 8-K | 2.02,9.01 | 0001728117-25-000022 | 001-38796 | 25735642 | 34 | 238796 | 1 | 1 |
| 2025-03-13 | 10-K | 10-K | 0001728117-25-000021 | 001-38796 | 25735631 | 34 | 10678447 | 1 | 1 | |
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000017 | 5461 | ||||||
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000015 | 5502 | ||||||
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000013 | 5510 | ||||||
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000012 | 5459 | ||||||
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000010 | 5451 | ||||||
| 2025-03-06 | 4 | FORM 4 | 0001728117-25-000008 | 5457 | ||||||
| 2025-02-19 | 8-K | 8-K | 8.01 | 0001728117-25-000004 | 001-38796 | 25639771 | 34 | 150729 | 1 | 1 |
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-018890 | 005-91334 | 25615268 | 34 | 18757 | |||
| 2025-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-002037 | 005-91334 | 25594858 | 34 | 10944 | |||
| 2025-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000166 | 005-91334 | 25575643 | 34 | 6315 | |||
| 2024-11-12 | SC 13G/A | SC 13G/A | 0001193125-24-256038 | 005-91334 | 241449173 | 34 | 146667 | |||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002720 | 005-91334 | 241444512 | 34 | 8146 | |||
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0001728117-24-000093 | 001-38796 | 241435411 | 34 | 440821 | 1 | 1 |
| 2024-11-07 | 10-Q | 10-Q | 0001728117-24-000092 | 001-38796 | 241435386 | 34 | 6747565 | 1 | 1 | |
| 2024-09-13 | 8-K | 8-K | 3.01 | 0001728117-24-000088 | 001-38796 | 241297654 | 34 | 154074 | 1 | 1 |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0001728117-24-000086 | 001-38796 | 241196658 | 34 | 450154 | 1 | 1 |
| 2024-08-12 | 10-Q | 10-Q | 0001728117-24-000085 | 001-38796 | 241196642 | 34 | 7832492 | 1 | 1 | |
| 2024-08-02 | SC 13G/A | SC 13G/A | 0001193125-24-193046 | 005-91334 | 241172621 | 34 | 191692 | |||
| 2024-07-18 | 8-K | 8-K | 8.01 | 0001728117-24-000080 | 001-38796 | 241124767 | 34 | 150825 | 1 | 1 |
| 2024-06-25 | 4 | FORM 4 | 0001728117-24-000078 | 5353 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001728117-24-000076 | 6031 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001728117-24-000073 | 5095 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001728117-24-000072 | 4598 | ||||||
| 2024-06-10 | 8-K | 8-K | 5.07 | 0001728117-24-000069 | 001-38796 | 241032600 | 34 | 165793 | 1 | 1 |
| 2024-06-06 | 4 | FORM 4 | 0001728117-24-000067 | 5549 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001728117-24-000066 | 5561 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001728117-24-000065 | 5613 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001728117-24-000064 | 5586 | ||||||
| 2024-05-24 | 8-K | 8-K | 3.01 | 0001728117-24-000059 | 001-38796 | 24984918 | 34 | 154034 | 1 | 1 |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0001728117-24-000057 | 001-38796 | 24921674 | 34 | 430190 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0001728117-24-000056 | 001-38796 | 24921659 | 34 | 5625485 | 1 | 1 | |
| 2024-05-06 | 8-K | 8-K | 1.01,1.02,3.02,8.01,9.01 | 0001728117-24-000052 | 001-38796 | 24915583 | 34 | 409372 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0001728117-24-000050 | 001-38796 | 24882100 | 34 | 16244740 | |||
| 2024-04-24 | DEFA14A | DEFA14A | 0001728117-24-000045 | 001-38796 | 24870506 | 34 | 197508 | |||
| 2024-04-24 | DEF 14A | DEF 14A | 0001728117-24-000044 | 001-38796 | 24870494 | 34 | 3374669 | 1 | 1 | |
| 2024-03-28 | 4 | FORM 4 | 0001728117-24-000041 | 6486 | ||||||
| 2024-03-28 | 4 | FORM 4 | 0001728117-24-000039 | 5741 | ||||||
| 2024-03-28 | 4 | FORM 4 | 0001728117-24-000037 | 5748 | ||||||
| 2024-03-19 | 4 | FORM 4 | 0001728117-24-000034 | 5056 | ||||||
| 2024-03-19 | 4 | FORM 4 | 0001728117-24-000033 | 5057 | ||||||
| 2024-03-12 | 4 | FORM 4 | 0001728117-24-000031 | 5332 | ||||||
| 2024-03-12 | 4 | FORM 4 | 0001728117-24-000029 | 5302 | ||||||
| 2024-03-12 | 3 | FORM 3 | 0001728117-24-000027 | 6373 | ||||||
| 2024-03-12 | 3 | FORM 3 | 0001728117-24-000026 | 6385 | ||||||
| 2024-03-12 | 8-K | 8-K | 5.02,9.01 | 0001728117-24-000024 | 001-38796 | 24741977 | 34 | 197003 | 1 | 1 |
| 2024-03-05 | S-8 | S-8 | 0001728117-24-000020 | 333-277653 | 24718297 | 33 | 189776 | |||
| 2024-03-05 | 10-K | 10-K | 0001728117-24-000019 | 001-38796 | 24718289 | 34 | 9725237 | 1 | 1 | |
| 2024-03-05 | 8-K | 8-K | 2.02,9.01 | 0001728117-24-000018 | 001-38796 | 24718286 | 34 | 224243 | 1 | 1 |
| 2024-03-04 | 8-K | 8-K | 8.01 | 0001728117-24-000013 | 001-38796 | 24714925 | 34 | 152783 | 1 | 1 |
| 2024-02-14 | SC 13G/A | GOSSAMER BIO, INC. | 0000902664-24-001739 | 005-91334 | 24639497 | 34 | 46058 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021039 | 005-91334 | 24628566 | 34 | 12983 | |||
| 2024-02-09 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO -- SCH 13G/A(#1-EXIT) | 0001072613-24-000116 | 005-91334 | 24616362 | 34 | 83587 | |||
| 2024-02-09 | SC 13G | filing.txt | 0000315066-24-001145 | 005-91334 | 24611633 | 34 | 8098 | |||
| 2024-01-11 | SC 13G | SC 13G | 0001193125-24-006630 | 005-91334 | 24529579 | 34 | 170146 | |||
| 2024-01-11 | SC 13G/A | GOSS_SC13GA1.htm | 0001273087-24-000008 | 005-91334 | 24529350 | 34 | 81545 | |||
| 2024-01-04 | 4 | FORM 4 | 0001728117-24-000010 | 5413 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001728117-24-000008 | 5454 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001728117-24-000006 | 5411 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001728117-24-000004 | 5403 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001728117-24-000002 | 5409 | ||||||
| 2023-12-05 | 4 | FORM 4 | 0001728117-23-000164 | 5386 | ||||||
| 2023-12-05 | 3 | FORM 3 | 0001728117-23-000163 | 6397 | ||||||
| 2023-11-29 | 4 | FORM 4 | 0001728117-23-000160 | 5177 | ||||||
| 2023-11-29 | 3 | FORM 3 | 0001728117-23-000158 | 6259 | ||||||
| 2023-11-29 | 8-K | 8-K | 5.02,9.01 | 0001728117-23-000157 | 001-38796 | 231452104 | 34 | 191948 | 1 | 1 |
| 2023-11-27 | 8-K | 8-K | 5.02,5.03,9.01 | 0001728117-23-000151 | 001-38796 | 231440281 | 34 | 692117 | 1 | 1 |
| 2023-11-22 | 4 | FORM 4 | 0001728117-23-000148 | 5333 | ||||||
| 2023-11-22 | 4 | FORM 4 | 0001728117-23-000147 | 5325 | ||||||
| 2023-11-22 | 4 | FORM 4 | 0001728117-23-000146 | 5335 | ||||||
| 2023-11-22 | 4 | FORM 4 | 0001728117-23-000145 | 5328 | ||||||
| 2023-11-22 | 4 | FORM 4 | 0001728117-23-000144 | 5376 | ||||||
| 2023-11-17 | 4 | FORM 4 | 0001728117-23-000138 | 4408 | ||||||
| 2023-11-14 | 4 | FORM 4 | 0001728117-23-000136 | 5430 | ||||||
| 2023-11-09 | 10-Q | 10-Q | 0001728117-23-000134 | 001-38796 | 231390080 | 34 | 5880424 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001728117-23-000133 | 001-38796 | 231390079 | 34 | 432776 | 1 | 1 |
| 2023-10-20 | 8-K | 8-K | 3.01 | 0001728117-23-000129 | 001-38796 | 231337151 | 34 | 157162 | 1 | 1 |
| 2023-09-07 | 8-K | 8-K | 5.02 | 0001728117-23-000127 | 001-38796 | 231242956 | 34 | 153310 | 1 | 1 |
| 2023-08-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-08-28 16:00:00 | 9999999995-23-002516 | 333-274056 | 231217933 | 33 | 1656 | ||
| 2023-08-28 | 424B3 | 424B3 | 0001728117-23-000124 | 333-274056 | 231216146 | 33 | 283827 | |||
| 2023-08-24 | UPLOAD | filename1.pdf | 0000000000-23-009357 | 40100 | ||||||
| 2023-08-24 | CORRESP | filename1.htm | 0001728117-23-000121 | 7351 | ||||||
| 2023-08-21 | DEL AM | DEL AM | 0001728117-23-000118 | 333-274056 | 231189089 | 33 | 7785 | |||
| 2023-08-18 | S-3 | S-3 | 0001728117-23-000116 | 333-274056 | 231183830 | 33 | 475247 | |||
| 2023-08-18 | RW | RW | 0001728117-23-000114 | 333-274045 | 231183828 | NE | 6873 | |||
| 2023-08-17 | S-3ASR | S-3ASR | 0001728117-23-000112 | 333-274045 | 231181814 | 33 | 477438 | |||
| 2023-08-08 | 10-Q | 10-Q | 0001728117-23-000108 | 001-38796 | 231151120 | 34 | 5951278 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001728117-23-000107 | 001-38796 | 231151070 | 34 | 431494 | 1 | 1 |
| 2023-08-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-23-006809 | 021-488995 | 231148172 | 33 | 15844 | ||
| 2023-07-28 | SC 13D | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / GOSSAMER BIO, INC. -- SCHEDULE 13D | 0001072613-23-000402 | 005-91334 | 231122852 | 34 | 445582 | |||
| 2023-07-26 | 4 | FORM 4 | 0001728117-23-000100 | 7216 | ||||||
| 2023-07-26 | 4 | FORM 4 | 0001728117-23-000099 | 7225 | ||||||
| 2023-07-26 | 4 | FORM 4 | 0001728117-23-000098 | 7957 | ||||||
| 2023-07-20 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001728117-23-000094 | 001-38796 | 231099719 | 34 | 732354 | 1 | 1 |
| 2023-07-20 | 8-K | 8-K | 8.01,9.01 | 0001728117-23-000091 | 001-38796 | 231098099 | 34 | 5067962 | 1 | 1 |
| 2023-06-26 | 4 | FORM 4 | 0001728117-23-000086 | 5703 | ||||||
| 2023-06-09 | 4 | FORM 4 | 0001728117-23-000084 | 5542 | ||||||
| 2023-06-09 | 4 | FORM 4 | 0001728117-23-000083 | 5599 | ||||||
| 2023-06-09 | 4 | FORM 4 | 0001728117-23-000082 | 5547 | ||||||
| 2023-06-09 | 8-K | 8-K | 5.03,5.07,9.01 | 0001728117-23-000081 | 001-38796 | 231005421 | 34 | 571789 | 1 | 1 |
| 2023-06-09 | 4 | FORM 4 | 0001728117-23-000079 | 5572 | ||||||
| 2023-06-09 | 4 | FORM 4 | 0001728117-23-000078 | 5595 | ||||||
| 2023-05-10 | SC 13G/A | GOSSAMER_BIO_INC.txt | 0000093751-23-000562 | 005-91334 | 23904608 | 34 | 8241 | |||
| 2023-05-09 | 4 | FORM 4 | 0001728117-23-000059 | 31450 | ||||||
| 2023-05-09 | 4 | FORM 4 | 0001728117-23-000057 | 31446 | ||||||
| 2023-05-09 | 4 | FORM 4 | 0001728117-23-000055 | 22129 | ||||||
| 2023-05-09 | 4 | FORM 4 | 0001728117-23-000053 | 26780 | ||||||
| 2023-05-09 | 4 | FORM 4 | 0001728117-23-000052 | 5928 | ||||||
| 2023-05-09 | DEFA14A | DEFA14A | 0001728117-23-000051 | 001-38796 | 23901860 | 34 | 32748 | |||
| 2023-05-09 | 8-K | 8-K | 2.02 | 0001728117-23-000050 | 001-38796 | 23901843 | 34 | 441273 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0001728117-23-000049 | 001-38796 | 23901798 | 34 | 5630869 | 1 | 1 | |
| 2023-05-05 | SC 13G/A | us38341p1021_050423.txt | 0001306550-23-009136 | 005-91334 | 23892238 | 34 | 12357 | |||
| 2023-04-28 | ARS | ARS | 0001728117-23-000042 | 001-38796 | 23865774 | 34 | 1908391 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001728117-23-000041 | 001-38796 | 23865757 | 34 | 1907723 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001728117-23-000040 | 001-38796 | 23865732 | 34 | 3782236 | 1 | 1 | |
| 2023-04-17 | PRE 14A | PRE 14A | 0001728117-23-000034 | 001-38796 | 23823924 | 34 | 3727299 | 1 | 1 | |
| 2023-04-05 | 4 | FORM 4 | 0001728117-23-000032 | 5467 | ||||||
| 2023-04-03 | 8-K | 8-K | 8.01 | 0001728117-23-000030 | 001-38796 | 23792540 | 34 | 156372 | 1 | 1 |
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000028 | 5370 | ||||||
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000026 | 5373 | ||||||
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000024 | 5371 | ||||||
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000022 | 8169 | ||||||
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000020 | 7425 | ||||||
| 2023-03-22 | 4 | FORM 4 | 0001728117-23-000018 | 11595 | ||||||
| 2023-03-20 | 4 | FORM 4 | 0001728117-23-000016 | 5010 | ||||||
| 2023-03-20 | 4 | FORM 4 | 0001728117-23-000014 | 5703 | ||||||
| 2023-03-20 | 4 | FORM 4 | 0001728117-23-000012 | 5013 | ||||||
| 2023-03-17 | 10-K | 10-K | 0001728117-23-000010 | 001-38796 | 23740695 | 34 | 10332995 | 1 | 1 | |
| 2023-03-17 | 8-K | 8-K | 2.02,9.01 | 0001728117-23-000009 | 001-38796 | 23740692 | 34 | 228461 | 1 | 1 |
| 2023-02-14 | SC 13G/A | GOSSAMER BIO, INC. | 0000902664-23-001807 | 005-91334 | 23629160 | 34 | 62334 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016055 | 005-91334 | 23603397 | 34 | 12907 | |||
| 2023-02-01 | SC 13G/A | us38341p1021_020123.txt | 0001306550-23-006437 | 005-91334 | 23577463 | 34 | 13197 | |||
| 2023-01-10 | SC 13G | Gossamer_Bio_Inc.txt | 0000093751-23-000003 | 005-91334 | 23519693 | 34 | 10251 | |||
| 2023-01-04 | SC 13G | GOSS_SC13G_2023.htm | 0001273087-23-000004 | 005-91334 | 23506743 | 34 | 81424 | |||
| 2022-12-20 | SC 13G | GOSS_SC13G.htm | 0001273087-22-000123 | 005-91334 | 221475091 | 34 | 81920 | |||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000114 | 5347 | ||||||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000112 | 5350 | ||||||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000110 | 5348 | ||||||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000108 | 5391 | ||||||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000106 | 5340 | ||||||
| 2022-12-09 | 4 | FORM 4 | 0001728117-22-000104 | 5343 | ||||||
| 2022-12-06 | 8-K | 8-K | 8.01,9.01 | 0001728117-22-000102 | 001-38796 | 221446706 | 34 | 5386736 | 1 | 1 |
| 2022-11-03 | 10-Q | 10-Q | 0001728117-22-000100 | 001-38796 | 221357830 | 34 | 6278550 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02 | 0001728117-22-000099 | 001-38796 | 221357789 | 34 | 456536 | 1 | 1 |
| 2022-10-27 | 4/A | FORM 4/A | 0001728117-22-000094 | 5918 | ||||||
| 2022-10-25 | 4 | FORM 4 | 0001728117-22-000092 | 4987 | ||||||
| 2022-10-25 | 4 | FORM 4 | 0001728117-22-000090 | 4983 | ||||||
| 2022-10-25 | 4 | FORM 4 | 0001728117-22-000088 | 5676 | ||||||
| 2022-08-09 | S-3ASR | S-3ASR | 0001728117-22-000086 | 333-266701 | 221148474 | 33 | 354087 | |||
| 2022-08-09 | 10-Q | 10-Q | 0001728117-22-000085 | 001-38796 | 221148252 | 34 | 6221561 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02 | 0001728117-22-000084 | 001-38796 | 221146498 | 34 | 452347 | 1 | 1 |
| 2022-07-18 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-014105 | 021-452776 | 221088970 | 33 | 13579 | ||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000078 | 5558 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000076 | 5539 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000073 | 5562 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000071 | 5562 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000069 | 5514 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000067 | 5509 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000065 | 4898 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000063 | 6293 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000061 | 5551 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001728117-22-000059 | 5558 | ||||||
| 2022-07-13 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001728117-22-000057 | 001-38796 | 221080253 | 34 | 770593 | 1 | 1 |
| 2022-07-05 | 4 | FORM 4 | 0001728117-22-000053 | 4978 | ||||||
| 2022-06-23 | 4 | FORM 4 | 0001728117-22-000051 | 5670 | ||||||
| 2022-06-10 | 8-K | 8-K | 5.07 | 0001728117-22-000049 | 001-38796 | 221008858 | 34 | 39633 | ||
| 2022-05-10 | 10-Q | 10-Q | 0001728117-22-000047 | 001-38796 | 22909626 | 34 | 5723966 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02 | 0001728117-22-000046 | 001-38796 | 22909485 | 34 | 283924 | ||
| 2022-05-05 | 4 | FORM 4 | 0001728117-22-000041 | 4584 | ||||||
| 2022-04-27 | DEFA14A | DEFA14A | 0001728117-22-000039 | 001-38796 | 22860389 | 34 | 254286 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001728117-22-000038 | 001-38796 | 22860362 | 34 | 962067 | |||
| 2022-04-25 | 8-K | 8-K | 2.02,8.01 | 0001728117-22-000035 | 001-38796 | 22847383 | 34 | 35450 | ||
| 2022-03-24 | 4 | FORM 4 | 0001728117-22-000033 | 6015 | ||||||
| 2022-03-24 | 4 | FORM 4 | 0001728117-22-000031 | 5733 | ||||||
| 2022-03-24 | 4 | FORM 4 | 0001728117-22-000029 | 5270 | ||||||
| 2022-03-17 | 4 | FORM 4 | 0001728117-22-000027 | 4978 | ||||||
| 2022-03-17 | 4 | FORM 4 | 0001728117-22-000025 | 4981 | ||||||
| 2022-03-17 | 4 | FORM 4 | 0001728117-22-000023 | 5671 | ||||||
| 2022-03-03 | S-8 | S-8 | 0001728117-22-000021 | 333-263260 | 22708684 | 33 | 181674 | |||
| 2022-03-03 | S-3ASR | S-3 | 0001728117-22-000020 | 333-263259 | 22708629 | 33 | 871183 | |||
| 2022-03-03 | 10-K | 10-K | 0001728117-22-000019 | 001-38796 | 22708596 | 34 | 10110688 | 1 | 1 | |
| 2022-03-03 | 8-K | 8-K | 2.02,9.01 | 0001728117-22-000018 | 001-38796 | 22708567 | 34 | 253819 | 1 | 1 |
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017665 | 005-91334 | 22609875 | 34 | 12900 | |||
| 2022-02-03 | SC 13G/A | us38341p1021_020322.txt | 0000834237-22-006295 | 005-91334 | 22589029 | 34 | 13278 | |||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000011 | 5346 | ||||||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000009 | 5349 | ||||||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000007 | 5347 | ||||||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000005 | 5392 | ||||||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000004 | 5339 | ||||||
| 2022-01-10 | 4 | FORM 4 | 0001728117-22-000002 | 5342 | ||||||
| 2021-11-08 | 10-Q | 10-Q | 0001728117-21-000104 | 001-38796 | 211387843 | 34 | 6326713 | 1 | 1 | |
| 2021-11-08 | 8-K | 8-K | 2.02,9.01 | 0001728117-21-000103 | 001-38796 | 211387822 | 34 | 460727 | 1 | 1 |
| 2021-10-26 | 4 | FORM 4 | 0001728117-21-000100 | 4589 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001728117-21-000098 | 4586 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001728117-21-000096 | 5279 | ||||||
| 2021-10-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001728117-21-000094 | 001-38796 | 211317222 | 34 | 413216 | 1 | 1 |
| 2021-09-21 | 8-K | 8-K | 5.02 | 0001728117-21-000092 | 001-38796 | 211264929 | 34 | 399158 | 1 | 1 |
| 2021-09-20 | 4 | FORM 4 | 0001728117-21-000091 | 5341 | ||||||
| 2021-08-09 | 10-Q | 10-Q | 0001728117-21-000087 | 001-38796 | 211156958 | 34 | 6771482 | 1 | 1 | |
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001728117-21-000086 | 001-38796 | 211156880 | 34 | 466671 | 1 | 1 |
| 2021-07-01 | 4 | FORM 4 | 0001728117-21-000080 | 4665 | ||||||
| 2021-06-22 | 4 | FORM 4 | 0001728117-21-000078 | 7009 | ||||||
| 2021-06-22 | 3 | FORM 3 | 0001728117-21-000076 | 15320 | ||||||
| 2021-06-14 | 4 | FORM 4 | 0001728117-21-000074 | 5238 | ||||||
| 2021-06-14 | 3 | FORM 3 | 0001728117-21-000072 | 6557 | ||||||
| 2021-06-14 | 8-K | 8-K | 5.02,5.07,9.01 | 0001728117-21-000071 | 001-38796 | 211014857 | 34 | 428412 | 1 | 1 |
| 2021-06-10 | 4 | FORM 4 | 0001728117-21-000068 | 5417 | ||||||
| 2021-06-10 | 4 | FORM 4 | 0001728117-21-000066 | 5417 | ||||||
| 2021-06-10 | 4 | FORM 4 | 0001728117-21-000064 | 5394 | ||||||
| 2021-06-10 | 4 | FORM 4 | 0001728117-21-000061 | 5364 | ||||||
| 2021-06-10 | 4 | FORM 4 | 0001728117-21-000058 | 5421 | ||||||
| 2021-05-06 | 10-Q | 10-Q | 0001728117-21-000056 | 001-38796 | 21897893 | 34 | 5651227 | 1 | 1 | |
| 2021-05-06 | 8-K | 8-K | 2.02,9.01 | 0001728117-21-000054 | 001-38796 | 21895880 | 34 | 447525 | 1 | 1 |
| 2021-05-05 | 4 | FORM 4 | 0001728117-21-000050 | 7003 | ||||||
| 2021-05-05 | 3 | FORM 3 | 0001728117-21-000048 | 12859 | ||||||
| 2021-04-27 | DEFA14A | DEFA14A | 0001728117-21-000045 | 001-38796 | 21859170 | 34 | 989793 | |||
| 2021-04-27 | DEF 14A | DEF 14A | 0001728117-21-000044 | 001-38796 | 21859068 | 34 | 1281319 | |||
| 2021-04-20 | 4 | FORM 4 | 0001728117-21-000040 | 7010 | ||||||
| 2021-04-20 | 3 | FORM 3 | 0001728117-21-000038 | 15660 | ||||||
| 2021-04-20 | 8-K | 8-K | 5.02,9.01 | 0001728117-21-000037 | 001-38796 | 21838460 | 34 | 246436 | 1 | 1 |
| 2021-03-25 | 4 | FORM 4 | 0001728117-21-000033 | 4642 | ||||||
| 2021-03-25 | 4 | FORM 4 | 0001728117-21-000031 | 5287 | ||||||
| 2021-03-25 | 4 | FORM 4 | 0001728117-21-000029 | 6016 | ||||||
| 2021-03-01 | 4 | FORM 4 | 0001728117-21-000027 | 8161 | ||||||
| 2021-03-01 | 4 | FORM 4 | 0001728117-21-000025 | 7783 | ||||||
| 2021-03-01 | 4 | FORM 4 | 0001728117-21-000023 | 8046 | ||||||
| 2021-03-01 | 4 | FORM 4 | 0001728117-21-000021 | 9158 | ||||||
| 2021-02-26 | 10-K | 10-K | 0001728117-21-000019 | 001-38796 | 21683852 | 34 | 9912691 | 1 | 1 | |
| 2021-02-25 | 8-K | 8-K | 2.02,9.01 | 0001728117-21-000015 | 001-38796 | 21676465 | 34 | 262920 | 1 | 1 |
| 2021-02-16 | SC 13G/A | GOSSAMER BIO, INC. | 0000902664-21-001418 | 005-91334 | 21638392 | 34 | 58224 | |||
| 2021-02-12 | SC 13G | SC 13G | 0001728117-21-000008 | 37289 | ||||||
| 2021-02-12 | SC 13G | SC 13G | 0001728117-21-000006 | 37442 | ||||||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-040874 | 005-91334 | 21625026 | 34 | 153763 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018196 | 005-91334 | 21610878 | 34 | 13762 | |||
| 2021-02-02 | SC 13G | us38341p1021_020221.txt | 0000834237-21-006835 | 005-91334 | 21580591 | 34 | 13221 | |||
| 2020-11-17 | 8-K | 8-K | 5.02 | 0001728117-20-000013 | 001-38796 | 201321994 | 34 | 192485 | 1 | 1 |
| 2020-11-10 | 10-Q | 10-Q | 0001728117-20-000009 | 001-38796 | 201301494 | 34 | 6596958 | 1 | 1 | |
| 2020-11-10 | 8-K | 8-K | 2.02,9.01 | 0001728117-20-000008 | 001-38796 | 201301278 | 34 | 262202 | 1 | 1 |
| 2020-10-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-054842 | 6983 | ||||||
| 2020-10-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-054841 | 5355 | ||||||
| 2020-10-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-054839 | 5870 | ||||||
| 2020-10-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001564590-20-046250 | 001-38796 | 201234616 | 34 | 8571334 | ||
| 2020-08-11 | 10-Q | 10-Q | 0001564590-20-039341 | 001-38796 | 201093044 | 34 | 7565090 | 1 | ||
| 2020-08-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-039333 | 001-38796 | 201092850 | 34 | 185365 | ||
| 2020-07-02 | 8-K | 8-K | 1.01,2.03,9.01 | 0001564590-20-031695 | 001-38796 | 201009822 | 34 | 150880 | ||
| 2020-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-20-038515 | 5874 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037679 | 5392 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037644 | 5422 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037640 | 5449 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037638 | 5445 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037635 | 5445 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037633 | 5389 | ||||||
| 2020-06-18 | 8-K | 8-K | 5.07 | 0001564590-20-029809 | 001-38796 | 20973219 | 34 | 49836 | ||
| 2020-06-09 | SC 13G/A | us38341p1021_060920.txt | 0000834237-20-009573 | 005-91334 | 20952237 | 34 | 12302 | |||
| 2020-05-21 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001564590-20-026546 | 001-38796 | 20901897 | 34 | 2527989 | ||
| 2020-05-19 | 424B5 | 424B5 | 0001564590-20-026207 | 333-237639 | 20894650 | 33 | 1447679 | |||
| 2020-05-19 | 424B5 | 424B5 | 0001564590-20-026204 | 333-237639 | 20894615 | 33 | 806920 | |||
| 2020-05-19 | FWP | FWP | 0001193125-20-145487 | 333-237639 | 20891536 | 34 | 51106 | |||
| 2020-05-18 | FWP | FWP | 0001193125-20-145156 | 333-237639 | 20890509 | 34 | 15776 | |||
| 2020-05-18 | 305B2 | 305B2 | 0001193125-20-145062 | 333-237639 | 20889906 | 33 | 139404 | |||
| 2020-05-18 | 424B5 | 424B5 | 0001564590-20-026003 | 333-237639 | 20889713 | 33 | 1314674 | |||
| 2020-05-18 | 424B5 | 424B5 | 0001564590-20-026001 | 333-237639 | 20889634 | 33 | 749164 | |||
| 2020-05-12 | 10-Q | 10-Q | 0001564590-20-024690 | 001-38796 | 20869526 | 34 | 6455119 | 1 | ||
| 2020-05-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-024672 | 001-38796 | 20869355 | 34 | 190582 | ||
| 2020-04-27 | DEFA14A | DEFA14A | 0001564590-20-018829 | 001-38796 | 20820261 | 34 | 132087 | |||
| 2020-04-27 | DEF 14A | DEF 14A | 0001564590-20-018824 | 001-38796 | 20820142 | 34 | 971189 | |||
| 2020-04-10 | S-3ASR | S-3ASR | 0001564590-20-016262 | 333-237639 | 20786962 | 33 | 1114391 | |||
| 2020-03-24 | 10-K | 10-K | 0001564590-20-012323 | 001-38796 | 20736754 | 34 | 11406806 | 1 | ||
| 2020-03-24 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-012321 | 001-38796 | 20736722 | 34 | 195567 | ||
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010521 | 7335 | ||||||
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010519 | 7802 | ||||||
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010517 | 9178 | ||||||
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010515 | 7990 | ||||||
| 2020-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-010512 | 8470 | ||||||
| 2020-02-14 | SC 13G | GOSSAMER BIO, INC. | 0000902664-20-001197 | 005-91334 | 20620667 | 34 | 60499 | |||
| 2020-02-14 | SC 13G | SC 13G | 0001193125-20-037460 | 005-91334 | 20616981 | 34 | 150502 | |||
| 2020-02-13 | SC 13G | ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO, INC. -- SCHEDULE 13G | 0001072613-20-000101 | 005-91334 | 20611619 | 34 | 330452 | |||
| 2020-02-11 | SC 13G | SCHEDULE 13G | 0001104659-20-016410 | 005-91334 | 20597435 | 34 | 13549 |
One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 6.12M | 2026-11-07 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 270.80M | 2025-06-28 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.78M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-09 | 0001728117-26-000052 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.22M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-09 | 0001728117-26-000052 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 9.20M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-09 | 0001728117-26-000052 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 2.30M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-09 | 0001728117-26-000052 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 143 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-09 | 0001728117-26-000052 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 1,560.14 | 2026-11-16 | S-3 | 2026-11-16 | 0001728117-26-000123 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 1,560.14 | 2026-11-16 | S-3 | 2026-11-16 | 0001728117-26-000123 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 17.93M | 2026-11-16 | S-3 | 2026-11-16 | 0001728117-26-000123 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-16 | S-3 | 2026-11-16 | 0001728117-26-000123 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-16 | S-3 | 2026-11-16 | 0001728117-26-000123 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 6,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 15.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.48M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 207,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -3.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.40B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 16,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-17 | 0001728117-23-000010 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.79M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 10.78M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 6.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | Assets | Assets | USD | 64.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 60.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 69,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 108.99M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year | USD | 298.57M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001728117-24-000092 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 265.52M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 109.06M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 15.88M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001728117-26-000072 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001728117-26-000072 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 51.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 51.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 326.91M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001728117-20-000009 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 13.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 22.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 2.04 | 2023-07-24 | 2024 | Q1 | 10-Q | 2024-05-07 | 0001728117-24-000056 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 32.47M | 2023-07-24 | 2024 | Q1 | 10-Q | 2024-05-07 | 0001728117-24-000056 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 30.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 6.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 6.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -76.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 37.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | -88,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -94,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 6,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 3.18M | 2026-06-04 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 | Debt Conversion, Converted Instrument, Warrants or Options Issued | shares | 1.88M | 2026-05-18 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | DebtCurrent | Debt, Current | USD | 11.61M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001728117-22-000100 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 30.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 109,000 | 2020-04-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-11 | 0001564590-20-039341 |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 1.45M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 3.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 1 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 894,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 20.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 2.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 274.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 30.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 132.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 5.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsOtherLossCarryforwards | Deferred Tax Assets, Other Loss Carryforwards | USD | 9.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 60.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 1.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 11.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 273.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxLiabilitiesFinancingArrangements | Deferred Tax Liabilities, Financing Arrangements | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001728117-24-000019 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 13,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | Depreciation | Depreciation | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 5,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001728117-26-000032 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -17.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -3.55 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -25.61 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.124 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.119 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | -0.047 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent | pure | 0.025 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.046 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.014 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | -0.083 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -112,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability | Embedded Derivative, Fair Value of Embedded Derivative Liability | USD | 37.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net | USD | 9.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 8.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 1.40M | 2023-05-05 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 43.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 54.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | FairValueEquityLevel1ToLevel2TransfersAmount | Fair Value, Equity, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | FairValueEquityLevel2ToLevel1TransfersAmount | Fair Value, Equity, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | -2.40M | 2021-10-29 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001728117-22-000100 | |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 43.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 37.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -138.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -170.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -32.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -243.36M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -88,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 4.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -35.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.28M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 5,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | USD | 14.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -3.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -5.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -49.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -2.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 1.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 16,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -9.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -9.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 87,449 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | InterestExpense | Interest Expense | USD | 3.13M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0001728117-24-000056 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 7.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | InterestOnConvertibleDebtNetOfTax | Interest on Convertible Debt, Net of Tax | USD | 4.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 5.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 1.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | InterestReceivable | Interest Receivable | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001728117-23-000134 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | InvestmentIncomeInterestAndDividend | Investment Income, Interest and Dividend | USD | 1.58M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-17 | 0001728117-23-000010 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.07 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-11 | 0001564590-20-039341 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 4.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 397,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.24M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 349,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 740,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | Liabilities | Liabilities | USD | 187.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 64.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 99.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | LitigationReserveCurrent | Estimated Litigation Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-17 | 0001728117-23-000010 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 28.55M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 4.17M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 4.17M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 10.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 10.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 5.83M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-12 | 0001564590-20-024690 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001728117-20-000009 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 21.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 100.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -107.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -77.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -77.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -117.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -14.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 18.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 128.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -63.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.80M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001728117-24-000092 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 3.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 697,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 15.75M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.94M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 1.69M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 3.22M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 3.12M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 3.04M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 1.74M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-24 | 0001564590-20-012323 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.50M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.124 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 765,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 424,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 1.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -68,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 1.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 200,000 | 2022-07-15 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 399.39M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 24.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 70.00M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 9.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-17 | 0001728117-23-000010 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 117.10M | 2020-05-21 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 73.49M | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001564590-19-030814 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 28.22M | 2019-01-01 | 2019-06-30 | 2020 | Q2 | 10-Q | 2020-08-11 | 0001564590-20-039341 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 23.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | ProceedsFromLongTermLinesOfCredit | Proceeds from Long-term Lines of Credit | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001728117-22-000019 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 205.75M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 25.50M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001564590-19-018973 |
| us-gaap | ProceedsFromSaleOfInvestmentProjects | Proceeds from Sale of Investment Projects | USD | 4.00M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 220,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 358,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -77.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 271,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 51,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 5,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 30,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0001728117-23-000108 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 88.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 15,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0001728117-23-000049 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-17 | 0001728117-23-000010 | |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 6.10M | 2026-03-16 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | individual | 73 | 2026-03-16 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.46 | 2026-03-16 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.52B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 64.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 13.25 | 2020-05-21 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 9.62 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001728117-22-000085 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001728117-24-000019 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 709,008 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 136.81 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 77,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 34.16 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 369,907 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 82.59 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 77,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 34.16 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 35.11 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 3.40M | 2023-05-05 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 83.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 40.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 6.82M | 2023-05-05 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 1.36 | 2023-05-05 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | SharePrice | Share Price | USD/shares | 239.2 | 2025-09-24 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 17,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -122.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.013 | 2026-09-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssued1 | Stock Issued | USD | 45.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 254.15M | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001728117-26-000072 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 9.43M | 2020-05-21 | 2024 | FY | 10-K | 2025-03-13 | 0001728117-25-000021 | |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | shares | 485,439 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001728117-22-000019 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationForfeited | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | shares | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001728117-23-000134 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 2,628 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 2.88M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 47.80M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 66,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 201.32M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 7.48M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2021-04-01 | 2021-06-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001728117-21-000104 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 220,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 3.43M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001728117-20-000009 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 0 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-09 | 0001728117-21-000087 |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 0 | 2018-07-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 15.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 1.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 2.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 45.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001728117-26-000017 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 1.13M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042943 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 4.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 68.51M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-26 | 0001728117-21-000019 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001728117-26-000114 |